Goa-based Molbio Diagnostics recently announced an $85mn fund raise from Singapore’s Temasek at an enterprise value of $1.5 bn reportedly making it India’s first ‘unicorn’ in the medical devices sector. Its flagship Truenat is a relatively low-cost, portable and miniaturised polymerase chain reaction (PCR) technology platform or micro PCR. The platform takes molecular biology testing for life-threatening … Continue reading The point-of-care bet. In conversation with Molbio’s founders
Correct me if I am wrong but I do believe that the Union Ministry of Health and Family Welfare just acknowledged that when prices of a product are fixed, manufacturers are discouraged from entering the market. And that competition brings down prices. Yes, you read that right, competition, and not price control. In a revealing … Continue reading “Come into my parlour..” India’s strange #medtech pricing decisions
India has decided to liberate foreign direct investment (FDI) in the medical devices sector from the conditions imposed on its pharmaceutical cousins. This begs the question : to what end? To recap, from January 21, FDI in medical devices will qualify for automatic approval of up to 100 per cent. Notably, this is irrespective of … Continue reading Will India’s new #FDI policy in #MedTech have the intended effect?